Related Experiment Video
Updated: Jul 1, 2026
07:08
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
AKT1 (E17K) mutation in pancreatic cancer
Azim Mohamedali1, Nicholas C Lea, Roger M Feakins
1Department of Haematological Medicine, Kings College London, 123 Coldharbour Lane, London.
Technology in Cancer Research & Treatment
|September 12, 2008
Summary
The AKT1 E17K mutation is not found in pancreatic cancer. Pancreatic cancer progression appears primarily driven by K-Ras mutations, not AKT1 alterations.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The AKT1 gene encodes a serine/threonine kinase crucial for cell survival and proliferation.
- Somatic mutations in cancer genes are key drivers of tumorigenesis.
- The E17K mutation in AKT1 has been implicated in various cancers, but its role in pancreatic cancer is unclear.
Purpose of the Study:
- To investigate the prevalence of the AKT1 E17K somatic mutation in pancreatic cancer.
- To determine if this mutation contributes to pancreatic cancer progression.
Main Methods:
- Quantitative pyrosequencing assay was employed.
- Analysis of DNA from pancreatic cancer tissue samples (n=65) and pancreatic cancer cell lines (n=10).
Main Results:
- The AKT1 E17K mutation was undetectable in all analyzed pancreatic cancer samples and cell lines.
- This finding suggests a lack of significant involvement of this specific AKT1 mutation in pancreatic cancer.
Conclusions:
- The AKT1 E17K mutation is not a common driver in pancreatic cancer.
- Pancreatic cancer progression is likely predominantly influenced by other genetic alterations, such as K-Ras mutations.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...